OOIR: Observatory of International Research

Papers

(The H4-Index of RSC Medicinal Chemistry is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Covalent cannabinoid receptor ligands – structural insight and selectivity challenges	134
Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery	97
Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives as potential antitubercular agents	74
Back cover	72
Inside front cover	68
Back cover	68
Contents list	63
Back cover	63
Design, synthesis and structure-activity relationship analysis of the dibenzodiazepinone derivatives against osimertinib resistant NSCLC	59
Emerging opportunities in the rewiring of biology through proximity inducing small molecules	59
4-Trifluoromethyl bithiazoles as broad-spectrum antimicrobial agents for virus-related bacterial infections or co-infections	57
N-Arylsulfonamide-based adenosine analogues to target RNA cap N7-methyltransferase nsp14 of SARS-CoV-2	55
New azole derivatives linked to indole/indoline moieties combined with FLC against drug-resistant Candida albicans	50
Research progress of anticancer drugs targeting CDK12	50
Thiazole orange-carboplatin triplex-forming oligonucleotide (TFO) combination probes enhance targeted DNA crosslinking	43
ATP-competitive inhibitors for cancer treatment – kinases and the world beyond	41
Unveiling sultam in drug discovery: spotlight on the underexplored scaffold	41
In vivo demonstration of enhanced mRNA delivery by cyclic disulfide-containing lipid nanoparticles for facilitating endosomal escape	40
Exploration of hydrazine-based small molecules as metal chelators for KDM4 inhibition	36
Integrating computational and experimental chemical biology revealed variable anticancer activities of phosphodiesterase isoenzyme 5 inhibitors (PDE5i) in lung cancer	34
Cytotoxicity of phosphoramidate, bis-amidate and cycloSal prodrug metabolites against tumour and normal cells	33
Biocompatible glycolipid derived from bhilawanol as an antibiofilm agent and a promising platform for drug delivery	32
Structure–activity relationship study of PROTACs against hematopoietic prostaglandin D₂ synthase	32
Development of sulfonyl fluoride chemical probes to advance the discovery of cereblon modulators	29
Effect of mono-guanidine-like derivatives on platelet aggregation and tumour cell induced platelet aggregation	29

Beta-cyclodextrin formulation of a disulfide-bond disrupting agent for improved systemic exposure	29
Unusual Ni⋯Ni interaction in Ni(ii) complexes as potential inhibitors for the development of new anti-SARS-CoV-2 Omicron drugs	27
Designing halogen-free metal–phenolic imidazolium poly(ionic liquids) with multi-functional antibacterial, anti-inflammatory and cell proliferation properties for infected wounds	27
Identification of the first structurally validated covalent ligands of the small GTPase RAB27A	27